Dupixent is a prescription biologic used to treat chronic rhinosinusitis with nasal polyps (CRSwNP), as well as asthma and eczema. It blocks inflammatory pathways that contribute to polyp formation and sinus symptoms, making it an ideal option for patients with recurring sinus surgery or who prefer a non-surgical approach.
Given by injection—either in-office or at home—Dupixent is FDA-approved and clinically proven to improve sense of smell, reduce nasal congestion, and shrink polyps over time. Dr. Kumra works closely with patients to assess candidacy, manage the injection schedule, and monitor progress.
If traditional therapies haven’t worked, Dupixent may offer lasting relief without the need for ongoing surgeries.
